Similar content being viewed by others Introduction/background Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) are a class of medications increasingly utilized in the treatment of type 2 diabetes and, more recently, obesity (Nathan et al
95% confidence interval, 0.72 to 0.90
This is to make sure that youre being safely evaluated and monitored in terms of your medical history and concerns, and that youre aware of any contraindications or side effects of the medication (which are headache, fatigue, and nausea and other GI issues)
Since IGF-1 can influence glucose utilization, clinicians typically evaluate meal timing, insulin response, and training intensity before determining administration timing
Biomarker and Genetic Context for Antioxidant Pathways Individual capacity to synthesize and recycle glutathione varies based on genetics